ITMCTR1900002271
Not yet recruiting
未知
A prospective randomized controlled study for the protective effect of Honghuang Decoction on cardiotoxicity of anthracyclines based on regulating oxidative stres
Jiangsu Provincial Hospital of Traditional Chinese Medicine0 sitesTBD
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Jiangsu Provincial Hospital of Traditional Chinese Medicine
- Status
- Not yet recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\.Pathologically confirmed breast cancer is treated with anthracycline\-containing chemotherapy regimens, including (adriamycin A or epirubicin E combined with cyclophosphamide C\*4\): doxorubicin 60 mg/m2 (or epirubicin 90 mg/m2\) cyclophosphamide 600 mg/m2\.
- •2\.Basic cardiac function was good before chemotherapy: NYHA cardiac function grade I; LVEF \> 55%; GLS \> 18; ECG was normal; cardiac troponin was in normal range.
- •3\.Perfect the relevant examinations before chemotherapy and eliminate the contraindications of chemotherapy.
- •4\.The age of the patients ranged from 18 to 70 years.
- •5\.Informed consent, volunteer subjects. The process of obtaining informed consent should comply with GCP.
Exclusion Criteria
- •1\.Persons with disabilities prescribed by law do have a history of alcohol and drug abuse.
- •2\.Chemotherapy contraindication for various diseases.
- •3\.Patients who are participating in clinical trials of other drugs.
- •4\.Pregnant and lactating women.
- •5\.Those who cannot give full informed consent due to intellectual or behavioral disorders.
- •6\.Suspected or true history of alcohol and drug abuse.
- •7\.According to the judgement of the researcher, other pathological changes, such as frequent changes in working environment, which can reduce the possibility of enrollment or complicate enrollment, are liable to lead to loss of interviews.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Recruiting
Not Applicable
A prospective randomized controlled study of the safty of phototherapy using green LED for neonatal hyperbilirubinemiaeonatal hyperbilirubinemiaJPRN-UMIN000039677Shikoku Medical Center for Children and Adults40
Completed
Phase 3
A prospective randomized controlled study of "one-step" vs "two-step" self-expandable metallic stent placement for the management of distal biliary obstruction by unresectable pancreatic cancer.Distal biliary obstruction caused by unresectable pancreatic cancerJPRN-UMIN000016010Department of Gastroenterology and Metabolism, Nagoya City University Graduate School of Medical Sciences, Nagoya, Japan90
Completed
Not Applicable
Prospective randomized controlled study about the adhesion prevention safety and effects for the general surgery using the absorbable adhesion barrier (INTERCEED) made of oxidized regenerated cellulose.colorectal cancerJPRN-UMIN000010314Kitasato University Department of Surgery100
Completed
Not Applicable
Prospective and randomized controlled study on the efficacy and safety of ipragliflozin and metformin to visceral fat reduction for the patients being treated with DPP-4 inhibitors for poor glycemic controlled type-2 diabetesType 2 diabetes mellitusJPRN-UMIN000015170Chiba University Hospital106
Active, not recruiting
Phase 3
Suppression of Prostate cancer by NaftopidilJPRN-jRCTs031180176Yamada Daisuke1,200